Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2009-08-31
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We hypothesize that children whose families are provided the language toolkit will develop more words over the subsequent 3 months.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Language Toolkit
Language toolkit composed of simple tools that parents can use to interact with child and help language acquisition.
Language toolkit
Simple toolkit of interactive things to stimulate language.
2
Safety counseling and smoke detector
Safety counseling
Smoke detector and general safety counseling
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Language toolkit
Simple toolkit of interactive things to stimulate language.
Safety counseling
Smoke detector and general safety counseling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Below average expressive language
* Otherwise normal development
Exclusion Criteria
* Non-English primary language
14 Months
19 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Steiner, MD
Asst. Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael J Steiner, MD
Role: STUDY_DIRECTOR
UNC Hospitals
Jennifer Hartz, MD
Role: PRINCIPAL_INVESTIGATOR
UNC Hospitals
Mary Ann Cross, MD
Role: PRINCIPAL_INVESTIGATOR
UNC Hospitals
Karen L Wysocki, MS, M Ed
Role: STUDY_DIRECTOR
UNC Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
North Carolina Children's Hospital
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-0549
Identifier Type: -
Identifier Source: org_study_id